The Burnley General Teaching Hospital is an acute District General Hospital in Burnley, Lancashire operated by the East Lancashire Hospitals NHS Trust.

During the past decade, Burnley General Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Burnley General Hospital" #1 sponsor was "Institute of Cancer Research, United Kingdom" with 4 trials, followed by "Chiesi UK" with 1 trials sponsored, "Gyroscope Therapeutics Limited" with 1 trials sponsored, "Hôpital Armand Trousseau" with 1 trials sponsored and "Medical Research Council" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Burnley General Hospital" #1 collaborator was "The Leeds Teaching Hospitals NHS Trust" with 2 trials as a collaborator, "Barts & The London NHS Trust" with 1 trials as a collaborator, "Birmingham Women's NHS Foundation Trust" with 1 trials as a collaborator, "City Hospitals Sunderland NHS Foundation Trust" with 1 trials as a collaborator and "Heart of England NHS Trust" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Burnley General Hospital" are "Breast Cancer" (3 trials), "Prostate Cancer" (3 trials), "Analgesia" (1 trials), "Breast Cancer Female" (1 trials) and "Bronchopulmonary Dysplasia" (1 trials). Many other conditions were trialed in "Burnley General Hospital" in a lesser frequency.

Most popular intervention types in "Burnley General Hospital" are "Drug" (8 trials), "Procedure" (2 trials), "Biological" (1 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "ADT" (1 trials), "Abemaciclib" (1 trials), "Abiraterone" (1 trials), "Aromatase Inhibitors" (1 trials) and "Celecoxib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Burnley General Hospital" are 6 trials for "All" genders, 3 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Burnley General Hospital". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Burnley General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Burnley General Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".